References
- Kibbe AE, ed. (2000). Handbook of pharmaceutical excipients. 3rd ed. London: Pharmaceutical Press.
- Berman HM, Rosenstein GA. (1968). The crystal structures of the α and β forms of d-mannitol. Acta Crystallogr B, 24:442–9.
- Debord B, Lefebvre C, Guyot-Hermann AM. (1987). Study of the different crystalline forms of mannitol: Comparative behaviour under compression. Drug Dev Ind Pharm, 13:1533–46.
- Giron D. (1990). Le polymorphisme des excipients. STP Pharma, 6:92–3.
- Grindley TB, McKinnon MS, Wasylishen RE. (1990). Towards understanding 13C-NMR chemical shifts of carbohydrates in the solid state, the spectra of D-mannitol polymorphs and DL‐mannitol. Carbohydr Res, 197:41–52.
- Jones FT, Lee KS. (1970). The optical and crystallographic properties of three phases of mannitol. Microscope, 18:279–85.
- Kim HS, Jeffrey GA, Rosenstein RD. (1986). The crystal structure of the K form of D-mannitol. Acta Crystallogr B, 24:1449–55.
- Walter-Levy L. (1968). Cristallochimie. Sur les variétés cristallines du D-mannitol. C R Acad Sci Paris Ser C, 267:1779–82.
- Haleblian J, McCrone W. (1969). Pharmaceutical applications of polymorphism. J Pharm Sci, 58:911–29.
- Brittain HG. (2001). X-ray diffraction III: Pharmaceutical applications of x-ray powder diffraction. Spectroscopy, 16:14.
- Kim AI, Akers MJ, Nail SL. (1998). The physical state of mannitol after freeze drying: Effects of mannitol concentration, freezing rate, and a noncrystallizing cosolute. J Pharm Sci, 87:931–5.
- Roberts SNC, Williams AC, Grimsey IM, Booth SW. (2002). Quantitative analysis of mannitol polymorphs. FT-Raman spectroscopy. J Pharm Biomed Anal, 28:1135–47.
- Burger A, Henck J, Hetz S, Rollinger JM, Weissnicht AA, Stottner H. (2000). Energy/temperature diagram and compression behaviour of the polymorphs of D-mannitol. J Pharm Sci, 89:457–68.
- Yoshinari T, Forbes RT, York P. (2002). Moisture induced polymorphic transition of mannitol and its morphological transformation. Int J Pharm, 247:69–77.
- Pellow-Jarmen MV, Hendra PJ, Lehnert RJ. (1996). The dependence of Raman signal intensity on particle size for crystal powders. Vib Spectrosc, 12:257–61.
- Reis MM, Araujo PHH, Sayer C, Giudici R. (2003). Evidences of correlation between polymer particle size and Raman scattering. Polymer, 44:6123–8.
- McCauley JA, Brittain HG. (1995). Thermal methods of analysis. In: Brittain HG, ed. Physical characterisation of pharmaceutical solids. New York: Marcel Dekker, 223.
- Shekonov BY, York P. (2000). Crystallisation processes in pharmaceutical technology and drug delivery design. J Cryst Growth, 211:122–36.
- Gaisford S, Buckton G. (2001). Application of microcalorimetry for physical processes in pharmaceuticals. Thermochim Acta, 380:185–98.
- Yoshinari T, Forbes RT, York P, Kawashima Y. (2003). Crystallisation of amorphous mannitol is retarded using boric acid. Int J Pharm, 258:109–20.